PA
ZYME icon

Parallel Advisors’s Zymeworks ZYME Stock Holding History

Parallel Advisors’s Portfolio ZYME Stock Details ZYME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8.81K Buy
352
+23
+7% +$544 ﹤0.01% 2811
2025
Q4 		$8.66K Hold
329
– – ﹤0.01% 2663
2025
Q3 		$5.62K Hold
329
– – ﹤0.01% 2736
2025
Q2 		$4.13K Hold
329
– – ﹤0.01% 2806
2025
Q1 		$3.92K Hold
329
– – ﹤0.01% 2763
2024
Q4 		$4.82K Hold
329
– – ﹤0.01% 2660
2024
Q3 		$4.13K Hold
329
– – ﹤0.01% 2677
2024
Q2 		$2.8K Hold
329
– – ﹤0.01% 2699
2024
Q1 		$3.46K Hold
329
– – ﹤0.01% 2643
2023
Q4 		$3.42K Buy
329
+13
+4% +$104 ﹤0.01% 2636
2023
Q3 		$2K Buy
+316
New +$2.33K ﹤0.01% 2817

Other funds holding ZYME

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Parallel Advisors's ZYME Position: Q1 2026 in Review

Parallel Advisors increased its Zymeworks (ZYME) stake by 7% in Q1 2026, buying an estimated $544 and bringing the position to 352 shares worth $8.81K. The position accounts for ﹤0.01% of the portfolio, ranked #2811.

Parallel Advisors first reported a position in ZYME in Q3 2023 and has held it in 11 quarters since. 211 funds tracked by Wall St. Rank hold ZYME as of Q1 2026.

  • Parallel Advisors held 352 shares of Zymeworks worth $8.81K as of Q1 2026.
  • Parallel Advisors bought 23 Zymeworks shares in Q1 2026, an estimated $544.
  • Zymeworks made up ﹤0.01% of Parallel Advisors's portfolio in Q1 2026, its #2811 holding.
  • Parallel Advisors first reported a position in Zymeworks in Q3 2023 and has held it in 11 quarters since.
  • 211 funds tracked by Wall St. Rank held Zymeworks as of Q1 2026.

Based on Parallel Advisors's 13F filing for Q1 2026, filed 7 May 2026.